Skip to main content

Advertisement

SpringerLink
Log in

Steroid-Responsive (Autoimmune?) Sclerosing Cholangitis

  • Original Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lee YM, Kaplan MM: Primary sclerosing cholangitis. N Engl J Med 332:924–933, 1995

    Article  PubMed  Google Scholar 

  2. Kim W, Therneau TM, Wiesner RH, Poterucha JJ, Benson JA, Jr, Malinchoc M, LaRusso N, Lindor K, Dickson ER: A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75:688–694, 2000

    PubMed  Google Scholar 

  3. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM, et al.: Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103:1893–1901, 1992

    PubMed  Google Scholar 

  4. Wiesner RH, Grambsch PM, LaRusso N, Dickson ER: Is primary sclerosing cholangitis a progressive disease or not? Hepatology 8:970–972, 1988

    PubMed  Google Scholar 

  5. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF: Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 10:430–436, 1989

    PubMed  Google Scholar 

  6. Alvarez FBP, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938, 1999

    Article  PubMed  Google Scholar 

  7. Kaplan MM: Medical approaches to primary sclerosing cholangitis. Semin Liver Dis 11:56–63, 1991

    PubMed  Google Scholar 

  8. Mistilis SP: Pericholangitis and ulcerative colitis. I. Pathology, etiology, and pathogenesis. Ann Int Med 63:1–16, 1965

    PubMed  Google Scholar 

  9. Mistilis SP, Skyring AP, Goulston SJM: Pericholangitis and ulcerative colitis; II. Clinical aspects. Ann Int Med 63:17–26, 1965

    PubMed  Google Scholar 

  10. Javett S: Azathioprine in primary sclerosing cholangitis. Lancet 1:810, 1971

    Article  Google Scholar 

  11. Wagner A: Azathioprine treatment in primary sclerosing cholangitis. Lancet 2:663–664, 1971

    Google Scholar 

  12. Myers RN, Cooper JH, Padis N: Primary sclerosing cholangitis: complete gross and histologic reversal after long-term steroid therapy. Am J Gastroenterol 53:527–538, 1970

    PubMed  Google Scholar 

  13. Burgert SL, Brown BP, Kirkpatrick RB, LeBrecqque DR: Positive corticosteroid response in early primary sclerosing cholangitis (abstract). Gastroenterology 86:1037, 1984

    Google Scholar 

  14. Kaplan MM, Arora S, Pincus SH: Primary sclerosing cholangitis and low dose oral pulse methotrexate. Ann Intern Med 106:231–235, 1987

    PubMed  Google Scholar 

  15. Knox TA, Kaplan MM: -Treatment of primary sclerosing cholangitis with oral methotrexate. Am J Gastroenterol 86:546–552, 1991

    PubMed  Google Scholar 

  16. Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, Meyer zum Büschenfelde K, Lohse A: Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. Ann Intern Med 131:943–946, 1999

    PubMed  Google Scholar 

  17. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K: High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 345:147–148, 2001

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard University, Cambridge

    Jasjeet S. Sekhon PhD

  2. Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Raymond T. Chung MD (Director of Hepatology)

  3. Gastroenterology Division, New England Medical Center, Boston, Massachusetts, USA

    Mark Epstein MD & Marshall M. Kaplan MD

  4. GRJ 825, GI Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA

    Raymond T. Chung MD (Director of Hepatology)

Authors
  1. Jasjeet S. Sekhon PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raymond T. Chung MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Epstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marshall M. Kaplan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond T. Chung MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sekhon, J.S., Chung, R.T., Epstein, M. et al. Steroid-Responsive (Autoimmune?) Sclerosing Cholangitis. Dig Dis Sci 50, 1839–1843 (2005). https://doi.org/10.1007/s10620-005-2948-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2948-3

Key Words

Search

Navigation